Hz Formula 12 X Liquid is a Health Canada–registered human drug (DIN 02234239) held by Bio Active Canada Ltd., containing Ranunculus Bulbosus. Health Canada lists its status as Cancelled Post Market (status date 28 Sep 2007). Nexara Health has matched 17 registrations of Ranunculus Bulbosus across 2 other regulated markets, 1 of them in the same strength and dosage form.
Health Canada registration
| DIN | 02234239 |
|---|---|
| Brand name | Hz Formula |
| Active ingredient | Ranunculus Bulbosus |
| Strength | 12 X |
| Dosage form | Liquid |
| Route | Oral |
| Company | Bio Active Canada Ltd. |
| Status | Cancelled Post Market — 28 Sep 2007 |
| Class | Human |
| ATC | |
| AHFS | 92:02.00* ; See footnote |
| Regulator record | Health Canada DPD entry · Product monograph |
Ranunculus Bulbosus registered in other markets
17 registrations of the same molecule in 2 national registries outside Canada (first 10 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| United States | Ranunculus Bulbosus | Herbamed AG | Liquid | FDA NDC | ||
| Netherlands | Ranunculus bulbosus | BOIRON (Messimy) | 4 DH t/m 60 DH#2 CH t/m 200 CH#6 K t/m 100.000 K#1 LM t/m 30 LM | Uitsluitend apotheek of drogist | EU national register | |
| Netherlands | Ranunculus bulbosus | BOIRON (Messimy) | 4 DH t/m 60 DH#2 CH t/m 200 CH#6 K t/m 100.000 K#1 LM t/m 30 LM | Globuli | Uitsluitend apotheek of drogist | EU national register |
| United States | Ranunculus bulbosus | Boiron | Pellet | listed | FDA NDC | |
| United States | Ranunculus bulbosus | Boiron | Pellet | listed | FDA NDC | |
| United States | Ranunculus bulbosus | Boiron | Pellet | listed | FDA NDC | |
| United States | Ranunculus bulbosus | Boiron | Pellet | listed | FDA NDC | |
| United States | Ranunculus bulbosus | Boiron | Pellet | listed | FDA NDC | |
| United States | Ranunculus bulbosus | Boiron | Pellet | listed | FDA NDC | |
| United States | Ranunculus Bulbosus | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC |
See every manufacturer of Ranunculus Bulbosus worldwide →
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Hz Formula (DIN 02234239) marketed in Canada?
No. Health Canada lists DIN 02234239 as Cancelled Post Market as of 28 Sep 2007.
Who holds the Canadian licence for this product?
Bio Active Canada Ltd. is the company of record in the Health Canada Drug Product Database.
Is Ranunculus Bulbosus registered outside Canada?
Yes — Nexara Health has matched 17 registrations in 2 other markets, including 1 in the same strength and dosage form (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 02234239, status date 2007-09-28; national medicine registries: EU national register, FDA NDC. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 02234239, status date 2007-09-28; national medicine registries: EU national register, FDA NDC.
Health Canada Drug Product Database (DPD), DIN 02234239, status date 2007-09-28; national medicine registries: EU national register, FDA NDC. Last reviewed 2026-09-17. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.